| abstract |
Disclosed is a foam comprising a liquid phase and a gas phase wherein the liquid phase comprises at least one sclerosing agent and the gas phase consists of at least one physiologically acceptable gas, physiologically acceptable gases being oxygen, carbon dioxide, nitrous oxide and helium, wherein gaseous nitrogen is present in the gas phase in an amount ranging from 0.0001 percent to 0.8 percent by volume. Also disclosed is a canister, the contents of which comprise said foam and the use of said foam for the manufacture of a medicament for phlebologic treatment. |